Additionally, we found a significant increase in the level of AIM2 transcript in the female critical (P<0.001) and severe (P=0.005) COVID-19 patients compared to the healthy control group (Figure 4D(Fig. 4)). The gene discussed is AIM2; the disease is COVID-19.